Across the broader market screening, around 215 smallcap firms delivered double-digit profit margins through the first two quarters of the fiscal year. Of these, 65 distinct stocks advanced between 50% and 350%, with 11 standout firms surging past the 150% threshold. The high-performing cohort included companies such as Bliss GVS Pharma, Menon Bearings, and Subex. Leading the entire screening in individual earnings profitability was Unimech Aerospace and Manufacturing, which kept margins above 26% across both periods.
Key points
Non-banking smallcap companies with sustained net margins above 10% delivered equity retu…: Non-banking smallcap companies with sustained net margins above 10% delivered equity returns between 151% and 352% during FY27.
Telecommunications and manufacturing players like HFCL and Raghav Productivity Enhancers…: Telecommunications and manufacturing players like HFCL and Raghav Productivity Enhancers combined substantial margin expansion with price gains topping 200%.
A total of 65 smallcap businesses that maintained double-digit margins managed to lift th…: A total of 65 smallcap businesses that maintained double-digit margins managed to lift their stock values by at least 50% in the fiscal period.
Sources checked by our analysis pipeline: 1
A consistently healthy net profit margin indicates a company's ability to manage costs and generate profits relative to its revenue. We screened the smallcap universe to identify companies that reported a net profit margin of over 10% in both Q1 and Q2FY27, excluding banking and financial services stocks. The screen threw up around 215 companies that met this criterion. Of these, 65 stocks have gained between 50% and 350% in FY27 so far. We have highlighted 11 stocks that have delivered price gains of over 150% in FY27 so far while maintaining a net profit margin of more than 10% in both quarters. (Data Source: ACE Equity)
Agencies
2/12
Sterlite Technologies
The stock has surged 352% in FY27 so far, climbing from Rs 176 to Rs 797. Its profit margin improved to 20.44% in the September 2026 quarter from 10.31% in the June 2026 quarter.
ETMarkets.com
3/12
HFCL
The stock has rallied 236% in FY27 so far, rising from Rs 68 to Rs 228. Its profit margin rose to 15.52% in the September 2026 quarter from 12.83% in the June…
The Bank of England raised its benchmark borrowing rate to 4% in its first hike in over three years, aiming to curb inflation by dampening consumer spending. While this shift increases returns for savers who move money away from older accounts, it escalates monthly expenses for variable-rate mortgage holders and threatens broader wage growth. Consequently, households face a mixed economic landscape characterized by higher borrowing costs and potential rent hikes.
Historical precedent suggests that cross-party collaboration in Washington can serve as an unexpected catalyst for significant equity gains. By examining past market surges, analysts point to previous eras where divided government successfully paired with aggressive monetary policy to foster growth. This perspective offers investors a framework for how political cooperation might influence future financial trends.
Analysts at the investment bank moved to lift their price target on the healthcare giant, expressing continued valuation confidence. The updated guidance follows the company's recent performance report, which delivered an uneven financial performance across key metrics. This adjustment signals institutional optimism about the firm's trajectory even when operational results fall short of an unqualified beat.